Managing Director at ElosMedtech Tianjin steps down

Elos Medtech AB announces today that Managing Director/Site Manager Paer Teike is leaving his position with Elos Medtech Tianjin in China. Paer Teike will remain in his current position during his period of notice and leave the company at midyear. The process of finding a successor for Paer starts immediately.

“I would like to thank Paer for his efforts during the time he has worked as Managing Director at Elos Medtech Tianjin,” says CEO Jan Wahlström. “He has in a positive way contributed to develop our business in China.” 

Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are internationally active medical technology companies.

Elos Medtech Group’s turnover is approximately MSEK 550 and has about 520 employees. The Group has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.

Gothenburg, 10 March 2017

Elos Medtech AB (publ)

For further information, please contact:
Jan Wahlström, CEO, 46 70 212 18 89, e-mail: jan.wahlstrom@elosmedtech.com

This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on March 10 at 13.30 (CET).

For additional information about the Elos Medtech Group, visit www.elosmedtech.com 

About Us

Elos Medtech is one of the leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental , Orthopedics and Life Science. Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.